Original article

Interleukin-10 polymorphism (-1082, G/A) on acute rejection risk in solid organ transplant recipients in a Caucasian population: a meta-analysis

Hyang Mi Jang*http://orcid.org/0000-0002-7348-622X
Author Information & Copyright
Department of Basic Nursing Science, school of nursing, Kyungdong University, Wonju 26495, Korea
*Corresponding author: Hyang Mi Jang, Department of Basic Nursing Science, school of nursing, Kyungdong University, Wonju 26495, Korea +82-33-738-1440, +82-33-738-1449, E-mail: she_said@kduniv.ac.kr

© Research Institute of Veterinary Medicine, Chungbuk National University. All rights reserved.

Received: Jul 29, 2016; Revised: Aug 29, 2016; Accepted: Sep 1, 2017

Abstract

Cytokines may play an important role in the acute rejection (AR) of solid organ transplantation. Many studies have investigated the association between interleukin-10 gene (IL-10) polymorphisms and risk of AR. The aim of this study was to determine the relationship between IL-10 polymorphism (-1082, G/A) and AR risk after solid organ transplantation in Caucasian population. A comprehensive electronic search of PUBMED, Google Scholar, and Korean databases was performed. Meta-analysis was performed using comprehensive meta-analysis software (Biostat, NJ,USA). We assessed the pooled p-value, odds ratio (OR), and 95% confidence interval (CI) to measure the association between the risk of AR and IL-10 polymorphism (-1082, G/A). The OR and 95% CI were used to evaluate the strength of the association. P-values less than 0.05 were considered statistically significant. Fourteen case-control studies were included in this meta-analysis. In overall analysis, we observed that IL-10 polymorphism (-1082, G/A) was associated with the AR in liver transplantation (G allele vs. A allele, OR = 1.436, 95% CI = 1.006-2.050, p = 0.046 in fixed model). However, IL-10 polymorphism (-1082, G/A) did not show any significant association with solid organ transplantation and renal transplantation (p>0.05 in each model, respectively). Our meta-analysis suggests that IL-10 polymorphism (-1082, G/A) may be related to susceptibility of AR in liver transplantation recipients.

Keywords: IL-10; polymorphism; acute rejection; meta-analysis; transplantation

Introduction

Despite improvements in surgical techniques and immunosuppressive therapies, acute rejection (AR) remains an important event after solid organ transplantation. Recently, there has been increasing interest in the role of cytokines in the occurrence of AR in solid organ allograft recipients. Cytokines may play an important role in the immunologic events that follow transplantation and therefore, may significantly influence the status of the graft.

Interleukin-10 (IL-10) is a cytokine that is produced by many cells, including monocytes, T-helper-2 cells, mastocytes, and a certain subset of activated T cells and B cells [1]. IL-10 has a key role in suppressing the immune response. It has multiple- and pleiotropic-effects in immune regulation [2, 3]. Emerging evidence showed that the expression of IL-10 is increased before a rejection episode [4]. It suggested that IL-10 may be closely correlated with the AR of allograft. In previous studies, relationships between IL-10 polymorphism (-1082, G/A) and rejection in organs including kidney, heart, and lung were reported. The IL-10 gene is located on human chromosome 1, which consists of 5 exons. The IL-10 polymorphism (-1082, G/A) in the promoter region has recently been identified. This polymorphism influences the capacity of cells to reduce IL-10 production [5].

Up to now, a number of studies have been conducted to evaluate the association between IL-10 polymorphism (-1082, G/A) and the risk of acute allograft rejection [6-19]. However, the results are conflicting rather than conclusive.

Meta-analysis is used as a statistical tool for combining results from different studies in the same topic and is becoming a popular method for resolving discrepancies in genetic association studies. Meta-analysis in polymorphisms studies is an effective tool in order to understand complex diseases and presentes new insight.

Therefore, we performed a meta-analysis of all eligible case-control studies to clarify the association between IL-10 polymorphism (-1082, G/A) and risk of AR in solid organ allograft recipients in a Caucasian population.

Materials and Methods

Search strategy

In order to identify all eligible studies, a comprehensive electronic search of PUBMED, Google Scholar, and Korean databases was conducted. The following keywords were used to search: IL-10, interleukin 10, allograft, transplantation, rejection, polymorphism, polymorphisms, genotype and variant. Additionally, the articles of relevant original studies and review articles were also screened to identify additional studies. No language restrictions were applied.

Inclusion criteria

Studies were included in our meta-analysis if they were designed as case-control studies that evaluated the association between the IL-10 polymorphism (-1082, G/A) and AR in a Caucasian population. The included studies must also contain a sufficient distribution of the IL-10 polymorphism (-1082, G/A) in both the AR group and non-AR group in order to calculate an odds ratio (OR), 95% confidence interval (CI), and p-value. The genotypes distribution in the control group was confirmed Hardy–Weinberg equilibrium using the goodness-of-fit test.

Data extraction

We extracted the following data from the included studies. The data included the name of the first author, year of publication, subject population, number of subjects, and genotype frequency of IL-10 polymorphism (-1082, G/A).

Statistical analysis

Meta-analysis was performed using comprehensive meta-analysis software (Biostat, NJ, USA). The pooled p-value, OR, and corresponding 95% CI were used to assess the strength of association between the risk of AR and IL-10 polymorphism (-1082, G/A). The significance of the pooled ORs was determined by the Z-test, and P-values <0.05 were considered statistically significant. Considering the possible sources of heterogeneity, the studies were stratified by genotype and the analysis was repeated separately for each group. First, to calculated the heterogeneity, the chi-square-based Q test and I2 test were applied. The random-effects Mantel–Haenszel method was used when the result of the Q test was p<0.05 or the I2 statistic was >50%. Otherwise, the fixed-effects Mantel–Haenszel method was adopted. To assess potential publication bias, the Egger's weighted regression method was performed.

Results

In order to evaluate the association between IL-10 polymorphism (-1082, G/A) and susceptibility of AR, we selected a total of eligible 14 articles (Table 1) [6-19]. Among 14 articles, the transplant organ types of AR were including renal (8 articles) and liver (6 articles). Table 2 and Fig.1 show the results of the overall meta-analysis of association between IL-10 polymorphism (-1082, G/A) and susceptibility of AR in allele model (A allele vs. G allele) and dominant model (G/G genotype vs. A/A+A/G genotypes).

Table 1. Information of eligible studies included in the meta-analysis
First author Year Ethnicity Transplant organ AR/non-AR AR Non-AR AR Non-AR
G/G A/A+A/G G/G A/A+A/G G A G A
Kocierz et al 2011 Caucasian Renal 143/56 41 102 2 54 135 151 53 69
Grinyo´ et al 2008 Caucasian Renal 112/108 13 99 33 75 51 71 146 172
Dmitrienko et al 2005 Caucasian Renal 50/50 14 36 19 31 48 52 58 42
Chen et al 2014 Caucasian Renal 50/275 14 36 63 212 28 72 126 424
Plothow et al 2003 Caucasian Renal 39/26 4 35 3 23 26 52 17 35
Hutchings et al 2002 Caucasian Renal 24/26 2 22 4 22 19 29 21 31
Hahn et al 2000 Caucasian Renal 32/81 6 26 24 57 26 38 86 86
Pelletier et al 2000 Caucasian Renal 32/67 9 23 12 55 32 32 53 81
Bathgate et al 2000 Caucasian Liver 68/76 22 46 16 60 44 92 32 120
Tambur et al 2001 Caucasian Liver 33/30 4 29 7 23 8 58 14 46
Warle´ et al 2002 Caucasian Liver 41/48 14 27 9 39 28 54 18 78
Fernandes et al 2002 Caucasian Liver 13/40 2 11 5 35 4 22 10 70
Mas et al 2004 Caucasian Liver 19/55 0 19 0 55 0 38 0 110
Karasu et al 2004 Caucasian Liver 26/17 2 24 2 15 4 48 4 30

AR: acute rejection; non-AR: non acute rejection.

Download Excel Table
Table 2. Overall analysis between IL-10 polymorphism (-1082, G/A) and susceptibility of AR
Organ Comparison Heterogeneity Association test Egger's regression p
p I2 Model OR (95% CI) p
All G vs. A 0.062 40.881 Fixed 1.078 (0.912-1.275) 0.378 0.704
 Renal G vs. A 0.345 10.943 Fixed 0.994 (0.822-1.202) 0.949 0.413
 Liver G vs. A 0.055 56.730 Fixed 1.436 (1.006-2.050) 0.046 0.227
All A/A+A/G vs. G/G 0.001 63.744 Random 1.036 (0.629-1.706) 0.890 0.644
 Renal A/A+A/G vs. G/G 0.001 72.404 Random 0.960 (0.483-1.906) 0.907 0.87
 Liver A/A+A/G vs. G/G 0.328 13.459 Fixed 1.436 (0.868-2.375) 0.159 0.227

AR: acute rejection; OR, odds ratio; CI, confidence interval.

Download Excel Table
jbtr-17-3-52-g1
Fig. 1. The results of the overall meta-analysis of association between -10 polymorphism (-1082 G/A) and susceptibility of AR in allele (G vs. A) model (right figure) and dominant (G/G genotype vs. A/A+A/G genotypes) model (left figure).
Download Original Figure

In allele model, heterogeneity among studies did not exist (heterogeneity p>0.05). Fixed model was applied in meta-analysis. When the G allele of IL-10 polymorphism (-1082, G/A) was compared with A allele, the overall meta-analysis revealed that G allele did not show any significant association with AR (OR = 1.078, 95% CI = 0.912-1.275, p = 0.378 in fixed model). And G allele of IL-10 polymorphism (-1082 G/A) were not also associated with AR in renal transplant recipients (OR = 0.994, 95% CI = 0.822-1.202, p = 0.413). However, G allele showed significant association with AR in liver transplant recipients (OR = 1.436, 95% CI = 1.006-2.050, p = 0.046 in fixed model).

In dominant model, heterogeneity among studies exists (heterogeneity p<0.05), not AR of liver group (heterogeneity p>0.05). Over analysis and analysis of AR in renal transplant recipients were applied with random model, and analysis of liver transplant recipients was applied with fixed model. G/G genotype applied random model did not show any significant association with overall AR (OR = 1.026, 95% CI = 0.629-1.706, p = 0.890). According to organ transplantation, G/G genotype of IL-10 polymorphism (-1082, G/A) was not associated with AR in renal and liver transplant recipients (p>0.05). To identify publication bias in meta-analysis, we evaluated publication bias using Egger's regression. There was no publication bias (p>0.05).

Discussion

Acute allograft rejection is thought to be the result from multiple immunological interactions between various cytokines. Genetic polymorphisms may affect individual differences in cytokine activity. Many studies have investigated the role of cytokine gene polymorphisms in solid organ allograft survival. IL-10 encodes a multifunctional anti-inflammatory cytokine that is involved in immunological activity after organ transplantation [1, 11]. A polymorphism of IL-10 has been identified at the −1082 on promoter region, which appears to be closely associated with the expression of IL-10 [5, 20].

Several studies have previously addressed the association between the IL-10 polymorphism (-1082, G/A) and the risk of acute allograft rejection. However, because of the difference in sample sizes, patient populations, and genetic background, the evidence provided by these studies is insufficient to confirm an association. One meta-analysis that investigated renal allograft outcomes reported that recipient IL-10 polymorphism (-1082, G/A) was associated with AR. The polymorphism was also associated with increased risk of recurrent AR. However, another meta-analysis investigating renal allograft outcomes demonstrated that this polymorphism was not associated with AR. Therefore, we conducted a meta-analysis including 14 case-control studies to evaluate the association between the IL-10 polymorphism (-1082, G/A) and the development of acute allograft rejection.

In our study, we examined the association of IL-10 polymorphism (-1082, G/A) with the risk for AR by meta-analysis. We found that this polymorphism was related to an increased risk of AR in liver transplantation recipients. The G allele of IL-10 polymorphism (-1082 G/A) showed risk of AR in liver transplantation recipients.

It is important to mention that we identified heterogeneity in some comparisons in our meta-analysis. To get a full and accurate detail of the data, we used a random-effects model or a fixed model. The results were stable after the sensitivity analysis, which did not change the results of the meta-analysis.

This meta-analysis still has some limitations that should be considered when evaluating the results. First, this meta-analysis was a secondary and retrospective study that is limited by the quality of the primary studies. Second, we were not able to analyze the gene-gene and gene-environment interactions.

In conclusion, the finding of our meta-analysis suggested that IL-10 polymorphism (-1082, G/A) may be related to susceptibility of AR in liver transplantation recipients. In the future, larger-scale studies are required to clarify and confirm this association.

REFERENCES

1.

Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annual review of immunology. 2001; 19:683-765.

2.

Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. The Journal of experimental medicine. 1999; 190:995-1004.

3.

Lalani I, Bhol K, Ahmed AR. Interleukin-10: biology, role in inflammation and autoimmunity. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 1997; 79:469-483.

4.

Platz KP, Mueller AR, Rossaint R, Steinmuller T, Lemmens HP, Lobeck H, Neuhaus P. Cytokine pattern during rejection and infection after liver transplantation--improvements in postoperative monitoring?. Transplantation. 1996; 62:1441-1450.

5.

Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics. 1997; 24:1-8.

6.

Chen Z, Bouamar R, Van Schaik RH, De Fijter JW, Hartmann A, Zeier M, Budde K, Kuypers DR, Weimar W, Hesselink DA, Van Gelder T. Genetic polymorphisms in IL-2, IL-10, TGF-beta1, and IL-2RB and acute rejection in renal transplant patients. Clinical transplantation. 2014; 28:649-655.

7.

Kocierz M, Siekiera U, Kolonko A, Karkoszka H, Chudek J, Cierpka L, Wiecek A. -174G/C interleukin-6 gene polymorphism and the risk of transplanted kidney failure or graft loss during a 5-year followup period. Tissue antigens. 2011; 77:283-290.

8.

Grinyo´ J, Vanrenterghem Y, Nashan B, Vincenti F, Ekberg H, Lindpaintner K, Rashford M, NasmythMiller C, Voulgari A, Spleiss O, Truman M, Essioux L. Association of four DNA polymorphisms with acute rejection after kidney transplantation. Transplant international : official journal of the European Society for Organ Transplantation. 2008; 21:879-891.

9.

Dmitrienko S, Hoar DI, Balshaw R, Keown PA. Immune response gene polymorphisms in renal transplant recipients. Transplantation. 2005; 80:1773-1782.

10.

Plothow A, Bicalho MG, Benvenutti R, Contieri FL. Interleukin-10 and acute rejection in renal transplantation. Transplantation proceedings. 2003; 35:1338-1340.

11.

Hutchings A, Guay-Woodford L, Thomas JM, Young CJ, Purcell WM, Pravica V, Perrey C, Hutchinson IV, Benfield MR. Association of cytokine single nucleotide polymorphisms with B7 costimulatory molecules in kidney allograft recipients. Pediatric transplantation. 2002; 6:69-77.

12.

Hahn AB, Kasten-Jolly JC, Constantino DM, Graffunder E, Singh TP, Shen GK, Conti DJ. TNF-alpha, IL-6, IFN-gamma, and IL-10 gene expression polymorphisms and the IL-4 receptor alpha-chain variant Q576R effects on renal allograft outcome. Transplantation. 2001; 72:660-665.

13.

Tambur AR, Ortegel JW, Ben-Ari Z, Shabtai E, Klein T, Michowiz R, Tur-Kaspa R, Mor E. Role of cytokine gene polymorphism in hepatitis C recurrence and allograft rejection among liver transplant recipients. Transplantation. 2001; 71:1475-1480.

14.

Pelletier R, Pravica V, Perrey C, Xia D, Ferguson RM, Hutchinson I, Orosz C. Evidence for a genetic predisposition towards acute rejection after kidney and simultaneous kidney-pancreas transplantation. Transplantation. 2000; 70:674-680.

15.

Bathgate AJ, Pravica V, Perrey C, Therapondos G, Plevris JN, Hayes PC, Hutchinson IV. The effect of polymorphisms in tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta1 genes in acute hepatic allograft rejection. Transplantation. 2000; 69:1514-1517.

16.

Karasu Z, Ulukaya S, Ayanoglu HO, Basturk B, Ulukaya E, Akyildiz M, Tokat Y. Cytokine gene polymorphism and early graft rejection in liver transplant recipients. Transplantation proceedings. 2004; 36:2791-2795.

17.

Mas VR, Fisher RA, Maluf DG, Archer KJ, Contos MJ, Mills SA, Shiffman ML, Wilkinson DS, Olive-ros L, Garrett CT, Ferreira-Gonzalez A. Polymorphisms in cytokines and growth factor genes and their association with acute rejection and recurrence of hepatitis C virus disease in liver transplantation. Clinical genetics. 2004; 65:191-201.

18.

Fernandes H, Koneru B, Fernandes N, Hameed M, Cohen MC, Raveche E, Cohen S. Investigation of promoter polymorphisms in the tumor necrosis factor-alpha and interleukin-10 genes in liver transplant patients. Transplantation. 2002; 73:1886-1891.

19.

Warle´ MC, Farhan A, Metselaar HJ, Hop WC, Perrey C, Zondervan PE, Kap M, de Rave S, K keboom J, Ijzermans JN, Tilanus HW, Pravica V, Hutchinson IV, Bouma GJ. Cytokine gene polymorphisms and acute human liver graft rejection. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2002; 8:603-611.

20.

Edwards-Smith CJ, Jonsson Jr, Purdie DM, Bansal A, Shorthouse C, Powell EE. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa. Hepatology. 1999; 30:526-530.